Westenfelder, Kay M;Lentes, Beatrice;Rackerseder, Julia;Navab, Nassir;Gschwend, Jürgen E;Eiber, Matthias;Maurer, Tobias
Gallium-68 HBED-CC-PSMA Positron Emission Tomography/Magnetic Resonance Imaging for Prostate Fusion Biopsy.
Clin Genitourin Cancer
2018
16
4
245-247

Pfetsch, L.;Schiller, K.;Devecka, M.;Maurer, T.;Eiber, M.;Combs, S.;Habl, G.
Follow-up of prostate cancer patients receiving 68Ga-PSMA-PET guided dose escalation radiotherapy
Radiother Oncol
2018
127
S859-S859

Schiller, K.;Devecka, M.;Maurer, T.;Eiber, M.;Combs, S. E.;Habl, G.
Patterns of failure in a primary staging setting for prostate cancer evaluated with PSMA-PET imaging
Radiother Oncol
2018
127
S433-S434

Seitz, Anna-Katharina;Thoene, Silvia;Bietenbeck, Andreas;Nawroth, Roman;Tauber, Robert;Thalgott, Mark;Schmid, Sebastian;Retz, Margitta;Gschwend, Juergen;Ruland, Juergen;Winter, Christof;Heck, Matthias
PREDICTION OF TREATMENT RESISTANCE UNDER ABIRATERONE AND ENZALUTMIDE VIA DETECTION OF AR-V7 IN PERIPHERAL WHOLE BLOOD OF CASTRATION-RESISTANT PROSTATE CANCER PATIENTS
J Urol
2018
199
4
E305-E305

Horn, Thomas;Rauscher, Isabel;Eiber, Matthias;Wester, Hans-Juergen;Schottelius, Margret;Heck, Matthias Michael;Gschwend, Juergen E.;Maurer, Tobias
Oncological and postoperative outcome of salvage PSMA-radioguided surgery in recurrent prostate cancer.
J Clin Oncol
2018
36
6

Rexer, H;Ohlmann, C-H;Retz, M
Erstlinientherapie beim lokal fortgeschrittenen oder metastasierten Urothelkarzinom: Eine randomisierte, kontrollierte Phase-III-Studie zum Vergleich von Pembrolizumab mit und ohne platinbasierter Kombinations-Chemotherapie und der alleinigen Chemotherapie bei Patienten mit fortgeschrittenem oder metastasiertem Urothelkarzinom (Keynote-361) AB 54/16 der AUO.
Aktuelle Urol
2018
49
1
21-22

Scheich, S.;Ahrens, M.;Goekbuget, N.;Boleti, E.;Burkholder, I;Escudier, B. J.;Goebell, P. J.;Gruenwald, V;Gschwend, J.;Retz, M.;Hartmann, A.;Maroto Rey, J. P.;Miller, K.;Grimm, M. -O;Siemer, S.;Panic, A.;Bergmann, L.
SUNNIFORECAST - A phase II study of Nivolumab in combination with Ipilimumab versus Standard of care in advanced or metastatic non-clear cell renal cell carcinoma
Oncology Research and Treatment
2018
41
205-205

Retz, M;Karl, A
[Bladder cancer : Current diagnosis and treatment modalities].
Urologe A
2018
57
6
655-656

Thalgott, Mark;Kron, Martina;Brath, Johannes M;Ankerst, Donna P;Thompson, Ian M;Gschwend, Juergen E;Herkommer, Kathleen
Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomy.
World J Urol
2018
36
2
177-185

Heers, Hendrik;Netsch, Christopher;Wilhelm, Konrad;Secker, Armin;Kurtz, Florian;Spachmann, Philipp;Viniol, Simon;Hofmann, Rainer;Hegele, Axel
Diagnosis, Treatment, and Outcome of Arterioureteral Fistula: The Urologist's Perspective.
J Endourol
2018
32
3
245-251